当前位置:药药网 / 数据中心 / 儿科研究特征电子表格
PANZYGA
通用名称
Immune Globulin Intravenous, human-ifas
儿科标签批准日期
2018/8/2 0:00:00
特定指示/秒
Indicated for 1) Primary humoral immunodeficiency (PI) in patients 2 years of age and older 2) Chronic immune thrombocytopenic purpura (ITP) in adults
标签更改摘要
See Package Insert for new information on biologics
研究年龄
2 YEARS - 75 YEARS
2 YEARS - 75 YEARS
学习类型
Efficacy,Safety,Pharmacokinetic
Efficacy,Safety,Pharmacokinetic
研究设计
Non-Randomized,Prospective,Single-arm,open-label,historical-controlled
Non-Randomized,Prospective,Single-arm,open-label,historical-controlled